IM Ketorolac 60mg for a 73-Year-Old Male with Acute Back Pain
No, a 60 mg IM dose of ketorolac is not appropriate for this 73-year-old patient—use 15-30 mg IM instead, as lower doses provide equivalent analgesia with reduced risk of adverse events in older adults.
Age-Specific Dosing Concerns
At 73 years old, this patient falls into the high-risk category for NSAID toxicity. Patients over 60 years are at significantly increased risk for renal, gastrointestinal, and cardiac toxicities from NSAIDs 1. The pharmacokinetics of ketorolac change with aging: elimination half-life increases from 4.5 hours in young adults to 7.0 hours in elderly patients, and total plasma clearance decreases 2. This means the standard 60 mg dose results in higher, more prolonged drug exposure in older adults.
Evidence-Based Dosing Recommendations
Recent high-quality evidence demonstrates that lower doses of ketorolac (15-20 mg IM) provide equivalent pain relief to 60 mg doses:
- A 2023 systematic review found that 15-20 mg ketorolac produces comparable pain reduction to ≥30 mg doses (mean difference 0.05 mm on 100 mm VAS; 95% CI -4.91 to +5.01) 3
- A 2021 military ED trial showed 15 mg IM ketorolac was non-inferior to 60 mg for acute musculoskeletal pain, with significantly fewer adverse effects (16.4% vs 1.8%, p=0.016) 4
- A 2025 meta-analysis confirmed no difference in analgesic efficacy between lower and routine doses across multiple pain types 5
Specific Recommendations for This Patient
Give 15-30 mg IM ketorolac as a single dose 1. The cancer pain guidelines specifically recommend "15-30 mg IV every 6 hours for maximum of 5 days" for short-term use, noting particular caution in patients over 60 years 1.
Key Safety Considerations:
Before administering ketorolac to this 73-year-old, assess:
- Renal function: Check baseline creatinine; avoid if compromised 1
- Cardiovascular history: NSAIDs increase MI risk; use lowest effective dose 6
- GI risk factors: History of peptic ulcer disease, alcohol use >2 drinks/day, or concurrent anticoagulants 1
- Bleeding risk: Ketorolac inhibits platelet aggregation 7
Duration Limits:
Do not exceed 5 days of treatment 8, 1. The migraine guideline lists ketorolac with a maximum of 120 mg per day and treatment not to exceed five days 8.
Alternative First-Line Approach
For acute back pain in a 73-year-old, acetaminophen should actually be considered first-line therapy before NSAIDs 6. The 2007 ACP/APS low back pain guidelines recommend acetaminophen as initial therapy due to its more favorable safety profile in older adults, despite being slightly less effective than NSAIDs 6. If acetaminophen at 1000 mg provides inadequate relief, then proceed to low-dose ketorolac.
Common Pitfalls to Avoid:
- Don't use the "standard" 60 mg dose reflexively—this outdated dosing increases adverse events without improving analgesia 3, 4
- Don't prescribe beyond 5 days—prolonged NSAID use dramatically increases toxicity risk 1, 7
- Don't ignore renal function—elderly patients have age-related GFR decline even with normal creatinine 1
- Don't combine with other NSAIDs or anticoagulants without careful risk assessment 1
The evidence strongly supports using 15-30 mg IM ketorolac rather than 60 mg for this elderly patient, providing equivalent pain control with substantially better safety profile 3, 4, 5.